Molecular Partners AG
MLLCF
$2.25
-$0.10-4.25%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -1.60% | -19.79% | |||
| Gross Profit | 1.60% | 19.79% | |||
| SG&A Expenses | 24.59% | -7.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.31% | -16.31% | |||
| Operating Income | -6.31% | 16.31% | |||
| Income Before Tax | -6.97% | 40.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.01% | 40.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.01% | 40.16% | |||
| EBIT | -6.31% | 16.31% | |||
| EBITDA | -9.25% | 16.88% | |||
| EPS Basic | -6.98% | 40.18% | |||
| Normalized Basic EPS | -8.37% | 32.06% | |||
| EPS Diluted | -6.98% | 40.18% | |||
| Normalized Diluted EPS | -8.37% | 32.06% | |||
| Average Basic Shares Outstanding | 0.04% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.04% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||